Clinical trials

Members
Messoud Ashina, Jes Olesen and Peer Tfelt-Hansen

Background
The Centre participates in number of clinical trials designed to test new therapies, or new ways of using known treatments to improve the treatment of headache disorders.

Current trials

• A multicenter, double-blind, placebo-controlled, parallel group multiple attacks study to compare the efficacy and safety of oral MK-0974 with placebo for the acute treatment of migraine with and without aura. Included 72 patients
• Study NXN-188-202. An investigator initiated, double-blind, placebo-controlled, cross-over study to compare the efficacy and safety of oral NXN-188 with placebo for the acute treatment of migraine with aura. Included 34 patients.